Levetiracetam Stada (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release and stabilises neuronal firing. This reduces excessive neuronal excitability, helping to prevent the initiation and spread of seizure activity.

The appropriate dose of Levetiracetam Stada is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and discuss options with the patient. Breastfeeding decisions should also be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancing agents such as valproate. It is generally well‑tolerated, has few drug‑enzyme interactions, and may be preferred when minimizing metabolic drug‑drug interactions is important.

Levetiracetam Stada tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Levetiracetam Stada is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with water and not chewed or crushed unless specifically instructed.

Serious risks include severe allergic reactions (e.g., Stevens‑Johnson syndrome), mood changes such as depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if they experience rash, swelling, mood disturbances, or unusual bleeding.

Levetiracetam Stada is contraindicated in patients with known hypersensitivity to levetiracetam or any of the tablet’s excipients. Caution is also advised for individuals with severe renal impairment who have not had dose adjustments, and for those with a history of serious psychiatric reactions.